The Diagnostic Imaging MRI modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of MRI across the healthcare continuum, including breast, neurological, cardiovascular, prostate imaging, and more.
April 16th 2025
An emerging nomogram model for intra-tumoral heterogeneity quantification with breast MRI demonstrated an average 85 percent sensitivity in external validation testing for predicting pathologic complete response to neoadjuvant chemotherapy for breast cancer.
Clinical Case Vignette Series™: 41st Annual Miami Breast Cancer Conference®
View More
Medical Crossfire®: How Can Thoracic Teams Facilitate Optimized Care of Patients With Stage I-III EGFR Mutation-Positive NSCLC?
View More
Lung Cancer Tumor Board®: How Do Emerging Data for ICIs, BiTEs, ADCs, and Targeted Strategies Address Unmet Needs in the Therapeutic Continuum for SCLC?
View More
26th Annual International Lung Cancer Congress®
July 25-26, 2025
Register Now!
2025 International Symposium of Gastrointestinal Oncology (ISGIO)
September 12-13, 2025
Register Now!
Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection
View More
(CME Credit Only) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(MOC and CME Credit) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(CME Credit Only) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(MOC and CME Credit) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
43rd Annual CFS: Innovative Cancer Therapy for Tomorrow®
November 12-14, 2025
Register Now!
20th Annual New York Lung Cancers Symposium®
November 15, 2025
Register Now!
Annual Hawaii Cancer Conference
January 24-25, 2026
Register Now!
43rd Annual Miami Breast Cancer Conference®
March 5-8, 2026
Register Now!
19th Annual New York GU Cancers Congress™
March 13-14, 2026
Register Now!
Mastering Advances in Managing Unresectable and Metastatic NSCLC—Immunotherapy, Targeted Therapies, and Emerging Strategies
View More
(CME Credit) Advancing Outcomes in Limited-Stage Small Cell Lung Cancer: From Evidence to Practice
View More
CMR extends influence to ventricular remodeling
May 1st 2006Figuring out how to treat postinfarction left ventricular remodeling using delayed-enhancement cardiac MR is not so cut and dried as it seems. Bright signal may signify dead myocardial tissue during DE-MR viability studies, but bright and dark myocardium both have stories to tell when dealing with remodeling.
Radiology can lead discussion of stroke therapy issues
May 1st 2006We have good news to report in this month's cover story: Research in stroke imaging is beginning to widen the window of time in which drug-based or mechanical therapy can be used to preserve brain function following an ischemic stroke. But we have bad news to report as well: More than a decade after research established the value of thrombolytic therapy to revascularize the brain and preserve brain tissue, the use of tissue plasminogen activator for stroke therapy remains stubbornly in the 2% range. Many victims go untreated for the nation's number three cause of death and a leading cause of serious long-term disability.
The window expands for more effective stroke treatment
May 1st 2006Buffalo psychologist Jamie Shiffner, Ph.D., beat the odds. The acute stroke patient was lucky enough to have everything go right after being struck down. With ischemic stroke, time is brain. Within moments of Shiffner's collapse at home on the evening of April 11, 2005, millions of neurons in his brain began dying every minute. The left side of Shiffner's body went numb, and attempts to talk resulted in nonsense phrases.
Study bolsters viability for MR of implanted devices
May 1st 2006MR imaging of pacemakers and implantable cardioverter devices is not for every imaging service. But the procedure is feasible, despite American College of Radiology recommendations to the contrary, according to a study from Oklahoma.
Dynamic contrast-enhanced MR imaging finally comes of age
May 1st 2006Tumors require new blood vessels in order to grow beyond a few millimeters in size. Once this "angiogenic switch" is thrown, a series of events occur that lead to the progression and spread of cancer. The vessels formed by tumors are not only larger and more numerous but also more permeable than normal vessels1 (Figure 1). Thus, when a patient with a tumor is injected with a gadolinium-chelate MR contrast agent, the tumor enhances more than the surrounding normal tissue.
MR arterial spin labeling proves feasible, safe in children
April 24th 2006High-field MR perfusion imaging with arterial spin labeling (ASL) can be performed safely and effectively on clinical pediatric populations for several neurological indications, according to Harvard University researchers.
Imaging tracks down brain’s oops! button
April 18th 2006We all make mistakes, and some cost more than others. Now, researchers have peered inside the brain to see what happens at the moment we realize our error -- and its price. Their findings may have implications for understanding obsessive-compulsive disorder.
High-field scanners assume routine clinical caseloads
April 14th 2006The market for 3T MRI is undoubtedly growing. Five years ago, few sites were using a 3T scanner for anything other than research. Now the higher field strength devices can be found in many clinical radiology departments and outpatient imaging clinics across the U.S. Clinical 3T is making inroads in Europe, too, though at a pace commensurate with its smaller MR base.
Experience overcomes difficulties of 3T MRI
April 14th 2006Whole-body MR scanners that operate at high field strengths are becoming widely available, and new 3T models have been launched in recent years. This generation of scanners offers exciting possibilities for radiological diagnosis while also posing challenges.
Manipulating brain's protective barricade can help researchers
April 14th 2006Neuroradiologists understand that high-grade tumors interrupt the blood-brain barrier, which presents as contrast enhancement on CT and MRI. Renewed interest in the phenomenon of permeability, however, has researchers looking beyond simple contrast enhancement and toward molecular mechanisms involved in permeability that may help them treat brain tumors more effectively.
Imaging genomics unveils roots of aggression
April 12th 2006An MR-based study has revealed associations between a gene variant and impulsive, violent behavior in humans, particularly males with a history of child abuse. The findings prompted National Institutes of Health director Dr. Elias A. Zerhouni to tout the power of imaging genomics to better understand brain circuitry underlying diversity in human temperament.
Report from SCBT/MR: Dynamic MR plays role in female urethra evaluation
April 4th 2006Imaging women with MR while they perform stress maneuvers can identify and characterize unsuspected pelvic organ prolapse, compared with imaging them while at rest, according to a study presented in Phoenix at the annual meeting of the Society of Computed Body Tomography and Magnetic Resonance.
Breast MR boosts detection of ductal carcinoma in situ
April 2nd 2006MR imaging has demonstrated a high sensitivity for detecting ductal carcinoma in situ, and it could play a complementary role to mammography in finding and evaluating this very common type of cancer, according to a study in The Breast Journal.
Dose concerns sway use of MR, CT in colon, brain
April 2nd 2006Among European radiologists, concerns about ionizing radiation exposure give MR an edge in specific applications, including colorectal cancer screening in younger patient populations. But in the U.S., such concerns have not dampened enthusiasm for CT, particularly in neurovascular studies.
High-field scanners assume routine clinical caseloads
April 2nd 2006The market for 3T MRI is undoubtedly growing. Five years ago, few sites were using a 3T scanner for anything other than research. Now the higher field strength devices can be found in many clinical radiology departments and outpatient imaging clinics across the U.S. Clinical 3T is making inroads in Europe, too, though at a pace commensurate with its smaller MR base.
Radiologic signs more than double sensitivity of MR imaging of knee
March 14th 2006Radiologists can make a more accurate preoperative diagnosis of damage to knee cartilage by using four radiologic signs, according to a study from Duke University Medical Center. Using the signs to identify the extent and type of damage to knee cartilage makes interpreting MRI with a higher degree of accuracy easier for any radiologist, regardless of level of expertise.
Breast MR boosts detection of ductal carcinoma in situ
March 13th 2006MR imaging has a high sensitivity for detecting ductal carcinoma in situ and could play a complementary role to mammography in finding and evaluating this common type of cancer, according to a study published in Breast Journal.
Whole-body PET/CT scans take on colon cancer, other new challenges
March 6th 2006A whole-body PET/CT scan can be used to stage and further pinpoint cancers spotted on optical colonoscopy, a research team for Essen University reported Monday. The team also reported that PET/CT scans may be useful in restaging recurrent breast cancer.